Company News
Alivus Acquires 76% Stake in IQGEN-X for ₹9.12 Crores
Alivus Life Sciences board approved acquiring 76% stake in IQGEN-X Pharma Private Limited for approximately ₹9.12 crores.
The acquisition aims to provide end-to-end solutions in API and CDMO space, ex